FP516
530
Dr.Gowri Jayadev Murthy
Membership No | Author Name | Mobile | |
---|---|---|---|
2614 | Dr.Sagar M S | [email protected] | 8123352625 |
Glaucoma
Dry eye and AGM
Aim of study: To analyze the meibomian gland(MG) function in patients on antiglaucoma medication(AGM) for ≥3 months & compare it against age-matched control group without AGM. Materials and methods: In this prospective observational study, primary open angle glaucoma patients(POAG),on ≥1 AGMs for ≥3 months, without any change in therapy were included. Dry eye evaluation; Slit lamp examination for TBUT. Lipiview: MG drop-out, lipid layer thickness (LLT) noted. Results: TBUT <10 in 18.1% & fluorescein staining in 11.1%.MG dropout in 68 eyes(68%), of which upto 25% dropout in 56.4%(p<0.001). Meiboscore <33% was noted in 52.1%, & LLT<64 nm in 31.9%. Carbonic anhydrase inhibitors(CAIs) were the most common AGM(68.1%). Patients on PGAs, 66.7% had TBUT>10 (p 0.001%)&87.1% had MG drop out 50% (p 0.009%). In the CAI group, 89%-TBUT>10(p 0.009%). Conclusion: Topical AGMs observed to affect MG drop-out,TBUT & LLT. This could point towards a lipid deficient dry eye in patients on AGM.
Membership No | Author Name | Mobile | |
---|---|---|---|
2674 | Dr.Vandana Sayra E A | [email protected] | 9686231264 |
1018 | Dr.Roopashri Matada | [email protected] | 9741765730 |
2615 | Dr.Surabhi P M | [email protected] | 8105407255 |